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Abstract: Biotechnological applications of cytochromes P450 show difficulties, such as low activity,
thermal and/or solvent instability, narrow substrate specificity and redox partner dependence. In an
attempt to overcome these limitations, an exploitation of novel thermophilic P450 enzymes from
nature via uncultured approaches is desirable due to their great advantages that can resolve nearly
all mentioned impediments. From the metagenomics library of the Binh Chau hot spring, an open
reading frame (ORF) encoding a thermostable cytochrome P450—designated as P450-T3—which
shared 66.6% amino acid sequence identity with CYP109C2 of Sorangium cellulosum So ce56 was
selected for further identification and characterization. The ORF was synthesized artificially and
heterologously expressed in Escherichia coli C43(DE3) using the pET17b system. The purified enzyme
had a molecular weight of approximately 43 kDa. The melting temperature of the purified enzyme
was 76.2 ◦C and its apparent half-life at 60 ◦C was 38.7 min. Redox partner screening revealed that
P450-T3 was reduced well by the mammalian AdR-Adx4-108 and the yeast Arh1-Etp1 redox partners.
Lauric acid, palmitic acid, embelin, retinoic acid (all-trans) and retinoic acid (13-cis) demonstrated
binding to P450-T3. Interestingly, P450-T3 also bound and converted testosterone. Overall, P450-T3
might become a good candidate for biocatalytic applications on a larger scale.
Keywords: thermostable P450; CYP109C; metagenomic; P450-T3; fatty acids; testosterone; biocatalyst;
redox partner; expression; half-life; melting temperature; Binh Chau hot spring
1. Introduction
Cytochromes P450 (CYPs) belong to one of the largest enzyme superfamilies, which is widely
distributed in all living organisms like bacteria, fungi, plants and animals [1,2]. They play a crucial
role in life by catalyzing more than 20 types of reactions in regio- and stereoselective manners,
such as hydroxylation, dealkylation, epoxidation, oxidation, dehalogenation, dehydrogenation and
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reduction. To carry out these functions, their substrates are also diversified, varying from drugs and
xenobiotics to complex substances, this way taking part in the metabolism of drugs, the biosynthesis
and metabolism of endogenous compounds and the biosynthesis of valuable substances [3]. Bacterial
P450s play an important role in xenobiotic bioremediation as well as in the diversification of natural
products due to their capacity to oxidatively degrade the natural substances and artificial chemicals
through hydroxylation or epoxidation and to perform the above mentioned reactions on natural
molecules [4]. Many reactions are difficult to perform chemically on a pilot and/or industrial scales,
especially when producing medical substances. One of the criteria for enzymes deployed on an
industrial scale is durability, including thermal stability [5]. However, the instability of P450s under
industrial production conditions, such as high temperatures and large amounts of organic solvents
limited their applications for large-scale production [6,7]. Consequently, seeking thermostable P450s
from nature has attracted attention. Thermostable P450s can be used in the production of valuable
organic compounds [8]. Furthermore, using thermostable P450s also has the advantage of building a
two-phase production system. Substrates of heat resistant P450 (usually organic compounds in nature)
can interact with enzymes in the solvent phase to be converted into diffusion products in the water
phase. The first known thermostable P450 (CYP119) was found in the archaea Sulfolobus solfataricus [9].
Initial characterization revealed that this enzyme had a melting temperature of approximately 90 ◦C,
which was determined by the differential scanning calorimetry method with a scan rate of 70 ◦C/h over
the temperature range 25–100 ◦C [10]. This melting temperature was considerably higher than that
of mesophilic P450s. CYP119 was capable of catalyzing the epoxidation of styrene and cis-stilbene
as well as the hydroxylation of fatty acids [11,12]. CYP175A1 of Thermus thermophilus HB27 was the
second heat resistant P450 described and recognized as the first P450 capable of hydroxylation of
β-carotene [13]. The melting temperature of CYP175A1 was 88 ◦C, while that of mesophilic P450s
ranged from 47–61 ◦C [14].
To date, a limited small number of thermostable P450 have been reported and they mainly belong
to several thermophiles, such as CYP119A1, CYP119A2, CYP174A1, CYP175A1, CYP231A2, CYP154H1
and several members of the CYP116B subfamily (CYP116B29, CYP116B46, CYP116B63, CYP116B64,
and CYP116B65) [15,16]. Furthermore, bacterial CYP102A2 and the human CYP2B subfamily and
CYP3 family were rationally or/and semi-rationally designed for greater thermostability [15–17].
Numerous microbial thermostable P450s still exist in nature and have not been exploited, especially
from nonculturable extremophillic microorganisms, where the enzyme cannot be acquired from a
conventional culture of the microorganisms. The Japanese Institute of Marine Biotechnology has
developed a “cassette PCR” method for sequencing genes coding for enzymes producing target
biological compounds. This method allows for obtaining a target DNA fragment from metagenomic
analysis of the environment and designates a gene that encodes the marker protein for active screening.
Kubota et al. [18] applied this method to acquire 16 new cytochrome P450 CYP153A genes from a
variety of environmental sources, such as oil-contaminated soil, groundwater, and n-alkane-degrading
bacterium Alcanivorax borkumesis SK2. The discovery of P450s from new sources or new species
continues to attract the exploration of metagenomic DNA. Kim et al. [19] discovered a gene that
encodes for a new self-sufficient P450, called syk181, from the metagenomic library of soil collected
from the Keryong Moutain, South Korea. The SYK181 shared a 46% amino acid sequence identity to
CYP102A1. Furthermore, CYP102A1 was only capable of metabolizing fatty acids, whereas SYK181 was
able to metabolize both fatty acids and aromatic compounds, such as naphthalene and phenanthrene.
These positive results inspired us to look for thermostable P450s in geothermal natural sources, such as
hot springs, oil-drilling, and volcanoes, by metagenomics approaches. Hot springs are suitable habitats
of thermophiles and extremophiles which have optimum growth temperatures above 55 ◦C and 80 ◦C,
respectively. Many enzymes exploited from those sources have been demonstrated to be extremely
useful for industrial and biotechnological purposes [20].
Vietnam is endowed with a diverse geothermal system with more than three hundred hot springs
scattered from the North to the South. The Binh Chau hot spring (10◦36′05.0′′ N and 107◦33′33.5′′ E)
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located in the Ba Ria province and is the second hottest hot spring in Vietnam. The average opened
mouth temperature is 80 ◦C, hence, this location is a potential resource for finding thermophiles and
thermostable enzymes. The sequencing and analysis of 9.4 Gb DNA metagenomics from the Binh
Chau hot spring by Illumina Hiseq Platform revealed the presence of 68 putative ORFs encoding for
putative monooxygenase enzymes, which belong to 36 different P450 subfamilies [21]. Based on the
melting temperature index program (http://tm.life.nthu.edu.tw/), a novel sequence, soluble P450-T3,
was selected due to its predicted melting temperature of >65 ◦C. Subsequently, its cDNA was
synthesized and expressed, and the protein was purified for characterization. The purified recombinant
enzyme showed thermal stability, coupled with several artificial electron transfers and bound a broad
spectrum of substrates.
2. Results
2.1. Identification and Bioinformatic Analyses of P450-T3
P450-T3 shared the highest sequence identity (69%) with cytochrome P450 CYP109C2 of Sorangium
cellulosum So ce56 at the amino acid level. P450-T3 also showed 66.6% identity with CYP109C2 from
S. cellulosum So ce56 according to Dr. Nelson’s Cytochrome P450 Homepage (https://drnelson.uthsc.
edu/CytochromeP450.html).
The phylogenetic tree obtained with MEGA X revealed that P450-T3 formed a cluster with other
members of the CYP109C subfamily, which were identified in S. cellulosum (Supplementary Figure S1),
suggesting that P450-T3 belongs to the CYP109C subfamily.
Multiple amino acid sequence alignments of P450-T3 with its closest homologs reveal the
presence of the three conserved domains of cytochrome P450 (Figure 1). The oxygen binding and
activation motif AGXXTT is located in I-helix (residues 222–227) [22], of which the highly conserved
threonine probably plays an important role in catalysis [23]. The EXXR motif (residues 261–264)
contains the conserved glutamic acid and arginine in all the cytochromes P450 that build a set of
salt-bridge interactions to form the final P450 tertiary structure [24]. The heme-binding domain motif
FXXGXXXCXG (residues 325–334) contains the three most conserved residues in the cytochrome P450
superfamily, including phenylalanine, glycine, and cysteine, of which the conserved cysteine plays the
role of the axial ligand to the heme [25].
2.2. Production and Purification of P450-T3
For expression purpose, the P450-T3 gene was successfully cloned into the pET17b vector and
expressed in the Escherichia coli C43(DE3) strain. The carbon monoxide (CO) difference spectrum was
recorded according to the Omura and Sato methods [26]. The results showed a typical peak with a
maximum at 450 nm without another peak at 420 nm (Figure 2a), indicating that the protein was
produced in an active conformation. The yield of recombinant P450-T3 was 585 nmol/L bacterial
cell culture before purification. The purified enzyme was shown to have a molecular weight of
approximately 43 kDa on SDS-PAGE as predicted (inset of Figure 2a). UV-Vis spectroscopy revealed
that P450-T3 contains a heme molecule as a prosthetic group, which is involved in the generation of the
Soret (γ) band at 418 nm (Figure 2b), and the smaller α and β bands at 567.5 and 536 nm, respectively
(inset of Figure 2b), indicating a low-spin state of heme iron.
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The secondary structure of an enzyme can be identified rapidly by using circular dichroism (CD)
spectroscopy. The CD spectra were recorded in the far-UV and near UV visible region. The far-UV
CD spectrum showed double bands with minima at 211 and 222 nm (Figure 2c), a representation of
combined contribution of helical and β-strand structures [27]. P450-T3 was predicted to consist of
64.16% regular secondary elements (53.77% the α-helix and 10.39% strand of β-sheet) and 35.84% coil
as an irregular secondary element (Supplementary Figure S2). In the near UV-visible region, P450-T3
displayed two large negative signals at 350 nm and at 408 nm (Figure 2d). These are in correspondence
with the characteristic peaks for other bacterial P450s [28,29].
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Figure 2. Spectroscopic characterization of P450-T3. (a) The typical carbon monoxide (CO) difference
spectrum of P450-T3. In the inset, SDS-PAGE of the expression and purification of P450-T3. Lane 1:
Precision protein marker (Biorad). Lane 2: Cell lysate after 48 h of expression. Lane 3: purified P450-T3.
(b) The UV–Vis spectral analysis of the purified P450-T3. The magnification of the spectrum in the α
and β band region was shown in the inset. The molar ellipticity was converted based on the circular
dichroism (CD) spectra in the far-UV (c) and in the near UV-Vis region (d).
2.3. Thermal Stability of P450-T3
The effect of temperature on P450-T3 structural integrity was investigated using various spectral
methods. P450-T3 showed the highest integrity at 50–60 ◦C and lost it at 70 ◦C (Figure 3a). The far-UV
CD spectra were recorded between 190–260 nm every 10 ◦C to determine the changes in their secondary
structure as a function of the temperature [30]. In the inset of Figure 3b, the appearance of an intense
negative minimum around 208 and 222 nm and a positive maximum around 197 nm confirmed the
existence of a predominant α-helical secondary structure [27]. The presence of an isodichroic point at
203 nm (inset of Figure 3b) indicated a dominant α to β structural thermal transition. The thermal
stability curve of P450-T3 was evaluated by recording the increment in the CD signal at a 211 nm
wavelength over the temperature range from 25–95 ◦C. At 70 ◦C, a little loss of magnitude of the
negative CD signal was observed, compared to those at temperatures of 30–60 ◦C. It means that,
at a temperature of ≥70 ◦C, P450-T3 lost helical secondary structure. This phenomenon was clearly
observed at 80 ◦C and 90 ◦C. The overlap of CD signals of protein P450-T3 at temperatures ≤60 ◦C
suggested that the helical secondary structure of P450-T3 was stable at 60 ◦C. Moreover, in the thermal
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stability curve determined by CD (Figure 3b), we observed that P450-T3 started to change the helical
structure at 67 ◦C. A rapid inactivation was shown after incubation at 80 ◦C. The calculated Tm was
76.2 ± 0.05 (R2 = 0.99).
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Figure 3. Thermal stability of P450-T3. (a) The optimal temperature of P450-T3 was evaluated through
CO difference spectroscopy after incubating the enzyme at 40, 50, 60 and 70 ◦C. (b) Melting curve of
P450-T3 recorded by circular dichroism (CD). The temperature slope of 1 ◦C per min with a resolution of
0.1 ◦C was used to determine the ellipticity at 211 nm as a function of temperature in the range between
25–95 ◦C. The inset shows far-UV CD spectra of P450-T3 at the indicated temperatures. Red circle
indicates the isodichroic point. Arrows show the direction of the peak by increasing the temperature at
211 nm. The CD spectra were recorded between 190–260 nm every 10 ◦C and converted into molar
ellipticity units. (c) The T1/2 of P450-T3 was identified at 60 ◦C from 0–60 min where the P450 content
was measured every 15 min.
Measuring the half-life (T1/2) at optimal temperature is another parameter for evaluating thermal
stability. The T1/2 of P450-T3 was determined by incubating the enzyme at 60 ◦C and measured by CO
difference spectroscopy every 15 min to calculate the relative stability (Figure 3c). The T1/2 of P450-T3
was 38.7 min at 60 ◦C.
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2.4. Identification of Electron Transfer Partners
Cytochromes P450s are heme-containing monooxygenases which require a coupled and stepwise
supply of electrons to start oxidation and hydroxylation reactions [3]. For efficient catalysis, P450s
require an electron transfer chain (in bacteria mostly a ferredoxin reductase and ferredoxin). In nature,
microorganisms can use autologous electron transfer partners. In this study, under laboratory conditions,
we tested the compatibility of P450-T3 with known ferredoxin reductase/ferredoxin partners, including
BmCPR-Fdx2, BmCPR-Fdx3, Arh1-Etp1 and AdR-Adx4-108. The diflavin reductase BmCPR and
ferredoxin Fdx2 are electron transfer partners of Bacillus megaterium DSM319. The BmCPR-Fdx2 system
efficiently supported the activity of CYP106A1 [31] and CYP107DY1 [32]. The bovine adrenodoxin
reductase homologue 1 Arh1 and its natural redox partner Etp1 are originated from Schizosaccharomyces
pombe [33]. The Arh1/Etp1 system was demonstrated to be efficient for a biotechnological application
with CYP105A1 from Streptomyces griseolus [34,35]. The bovine adrenodoxin reductase (AdR) and
adrenodoxin (Adx4-108) were identified as the most efficient redox partners for several myxobacteria
cytochrome P450s [36,37].
The redox partners were compared on the base of the spectra of the reduced CO-complexed
enzyme of P450-T3 (Figure 4). The redox partners BmCPR-Fdx3 did not produce a significant Soret peak
at 450 nm. The redox partners BmCPR-Fdx2 reduced by ~15% in the CO complex sample. The systems
AdR-Adx4-108 and Arh1-Etp1 showed a higher efficiency with ~30% of peak recovered (compared to
dithionite). The redox system AdR-Adx4-108 was selected for further investigation of P450-T3.
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Figure 4. Screening of electron transfer partners for P450-T3. The dithionite reduced CO-difference
spectrum (black solid line) was compared with the CO-complex spectrum after reduction by
AdR-Adx4-108 (gray dash line), Arh1-Etp1 (black dash–dot line), BmCPR- Fdx2 (black dash line),
and BmCPR- Fdx3 (gray solid line). The baseline is shown as a dotted line. A 1 mL mixture of
P450-T3:ferredoxin:ferredoxin reductase (1:40:5) dissolved in 50 mM HEPES buffer (pH 7.4). NADPH
solution (1 mM) was supplemented for starting the reduction.
2.5. Substrate Screening for P450-T3
Seeking for the substrate specificity of an individual cytochrome, P450, especially of a novel
enzyme, is a significant effort that helps to expand its potential application. Since P450-T3 was identified
as a close relative of CYP109C2 from S. cellulosum So ce56—which is a fatty acid hydroxylase [38],
lauric acid, palmitic acid—and other substances sharing a structural part of fatty acids, such as retinoic
acid (all-trans), and retinoic acid (13-cis) and embelin were used to evaluate their ability to bind to
P450-T3. The results showed a transition from low-spin state to high-spin state of the heme pocket
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for all the substances used (Table 1), indicating a broader potential substrate spectrum for P450-T3 in
comparison with CYP109C2.
Table 1. Substrate binding of P450-T3.




Retinoic acid (all-trans) +






+ indicates binding and - indicates no binding of the substrate to the P450-T3 was detected.
Enzyme members of the CYP109 subfamilies have different substrate specificities. For example,
CYP109A2 from B. megaterium DSM319 was involved in vitamin D3 hydroxylation [39], whereas
CYP109D1 from S. cellulosum So ce56 was demonstrated to oxidize norisoprenoids [40]. CYP109E1
from B. megaterium DSM319 [41] and CYP109B1 from B. subtilis W23 [42] showed the capacity of
steroid conversions. Besides steroid conversion, CYP109B1 was reported to hydroxylate α- and
β-ionone [43]. To date, CYP109E1 has shown the broadest substrate spectrum, being involved not
only in steroid conversion, but also in the hydroxylation of vitamin D3, vitamin D2, cholesterol,
statins, and terpenes [39,41,44,45]. Therefore, P450-T3 might also exhibit novel characteristics,
including an altered substrate specificity. In this study, nootkatone and several steroids, such as
11-deoxycorticosterone (DOC), 11-deoxycortisol (RSS), progesterone, and testosterone were tested.
Interestingly, testosterone was observed to bind to P450-T3 (Table 1). It was further investigated in
in vitro conversion assays. Using the redox system AdR-Adx4-108 for in vitro reconstitution, P450-T3
showed the ability to convert testosterone into two products at a retention times of 13.5 and 15 min,
respectively (Figure 5). The conversion ratio of 100 µM testosterone was ~ 11% in total after 30 min.Catalysts 2020, 10, x FOR PEER REVIEW 9 of 18 
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Figure 5. HPLC analysis of the in vitro conversion of testosterone with P450-T3. The reaction was
carried out in 50 mM HEPES buffer (pH 7.4) with 20% glycerol. The black line indicates negative control
(testosterone without P450-T3) and the red line represents for testosterone converted by P450-T3 for
30 min at 37 ◦C.
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3. Discussion
Recently, considerable attention has been paid towards identification and characterization of
new thermostable P450s due to their potential use in industrial processes. Until now, only few
thermostable P450s were found from thermophilic microorganisms in nature, including CYP119
from S. solfataricus [46], CYP119A1 from T. thermophilus [14], CYP119A2 from S. tokodaii [47],
CYP175A1 from T. thermophilus [13], CYP154H1 from Thermobifida fusca [48], CYP231A2 from
P. torridus [49], and CYP116B subfamilies from several archaea species [15,16]. However, the number
of thermostable cytochrome P450s is still insufficient for versatile biocatalysis on a larger scale.
To enhance the catalytic efficiency, different strategies have been used, such as the engineering of
proteins, redox–partner interactions, substrates, and electron sources [50], of which the improvement
in cytochrome P450s is the main effort and challenge. Besides the molecular evolution of these
enzymes, another approach—metagenomics—was introduced in 2004 by Handelsman et al. [51].
Until now, metagenomics is a well-accepted power tool for exploiting the microbial genome in a
natural environment. Several enzymes have been successfully discovered using this method, such as
hydrolases [52–56], oxidoreductases [57], dehydratases [58], and cytochrome P450s (e.g.,CYP153A
members) [18]. Recently, 264 putative CYP153 proteins were identified from the metagenomic
dataset obtained from 23 sediment samples [59]. Their characteristics were computed to point out a
highly promising application for catalysis using a broad variety of substrates under cold conditions.
The advantage of using metagenomics is especially visible in extreme habitats, such as geothermal
ecologies (volcanoes, hot spring) and offshore oil platform. Most of the thermostable enzymes have
been produced by thermophilic microorganisms in hot springs or through metagenomic analysis of this
environment [60–62]. Vietnam has a diverse hot spring system which allows us to find desired enzymes.
To the best of our knowledge, this is one of the first examples of identifying thermostable cytochrome
P450s that rely on metagenome-based sequences in the Binh Chau hot spring. Here, we report on the
characterization of one of them, P450-T3. Bioinformatic analyses of the amino acid sequence of P450-T3
indicated that it shares the highest identity with CYP109C2 of S. cellulosum So ce56. However, P450-T3
does not belong to the CYP109C2 subfamily due to a moderate bootstrap value. This finding might
indicate a novel CYP109C subfamily, which is one of the smallest families among bacterial P450s with
so far only eight subfamily members (https://cyped.biocatnet.de/sFam/109). Moreover, analyses of 16S
rRNA database in the metagenomics of the Binh Chau hot spring revealed that S. cellulosum accounts
for ~0.00438% (data not shown). Therefore, it was supposed that P450-T3 might have originated from
this myxobacterial species.
As compared to other thermostable cytochrome P450s, P450-T3 showed an optimal temperature
of 60 ◦C, which is lower than that of CYP119A1 from S. solfataricus (70 ◦C [9]), but higher than that
of CYP154H1 from T. fusca (50–55 ◦C [48]). The melting temperature of P450-T3 was calculated to be
76.2 ◦C, which was higher than that of CYP154H1 (67 ◦C [48]) and CYP231A2 (65 ◦C [49]), but lower
than those of CYP119A1 (90 ◦C [9]) and CYP175A1 (87 ◦C [13]). The thermal stability of a protein was
ascribed to a variety of global aspects, as described by Yano et al. [14], Zhou et al. [63], and Lee et al. [64].
In comparison with the mesophilic P450BM-3, the thermostable P450-T3 shows an increase in alanine
(11.7% versus 9.1%) and arginine residues (8.6% versus 4.2%) and a decrease in lysine (2.3% versus
6.7%) and glutamine residues (4.4% versus 5.2%). Alanine is the best-helix-forming residue [65];
therefore, a higher alanine content in the α-helix (16.43% versus 12.15%) in P450-T3 may make the
protein more thermal stability. The reduction in glutamine in P450-T3 is consistent with the findings of
several studies [66,67], in which the composition of uncharged polar residues (glutamine, threonine,
serine) is much lower in thermophiles than those in mesophiles.
On the other hand, the half-life (T1/2) of an enzyme is an important index to evaluate its stability.
Protein engineering has a great impact on enzyme stability. CYP102A1 from B. megaterium was
engineered to strengthen the thermal stability of the reductase domain, which led to an increase in
the optimal temperature from 25 to 40 ◦C and prolonged its half-life at 50 ◦C ten-fold [68]. Moreover,
Urlacher et al. [69] created a library of chimeric fusion proteins by exchanging the unstable reductase
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domain of CYP102A1 with the more stable reductase domain of CYP102A3, resulting in a chimeric
protein displaying a wider temperature range and broader substrate specificity. The T1/2 of the new
chimeric protein at 50 ◦C was 100 min, which was more than ten-fold longer than that of the wild
type. P450-T3 displayed a T1/2 at 60 ◦C of 37.5 min, which is a moderate thermostability as compared
to other CYPs. However, as described for CYP102A1, it might be further increased by using protein
engineering techniques, such as site-directed mutagenesis or directed evolution.
P450-T3 is an external monooxygenase. Therefore, it requires an external electron donor in the
electron transfer chain to transfer electrons from NADPH to its heme for substrate hydroxylation.
In this study, the used redox pairs BmCPR-Fdx2 and BmCPR-Fdx3, originating from B. megaterium,
were not or only partly able to interact with P450-T3. Similar to CYP109C1 and CYP109C2 from
S. cellulosum So ce56, P450-T3 accepted the reduction equivalents from bovine AdR- Adx4-108 and yeast
Arh1-Etp1 [38]. However, the reduction yield of P450-T3 was low, (Figure 5). Hence, a suitable ratio
between P450-T3 and the redox partner may be identified in the future to optimize the electron transfer.
The next important question was to identify possible substrates for P450-T3. The similarity to
CYP109C1 and CYP109C2 from S. cellulosum So ce56 indicated the ability to bind to medium-chain
fatty acid (lauric acid) and unsaturated long-chain fatty acids (e.g., palmitic acid). As shown in Table 1,
the substrate spectrum binding to P450-T3 is more diverse than that of the thermostable CYP175A1,
which only showed the ability to bind to some unsaturated monoenoic fatty acids but not to saturated
fatty acids [70]. It has to be demonstrated in future studies whether the bound substrates can also be
converted by P450-T3, since this not always the case [71]. Lauric acid and palmitic acid are the main
fatty acids in coconut oil and palm kernel oil; therefore, P450-T3 might be used in oil production in
the future. Moreover, long aliphatic chain (embelin) and tretinoins (retinoic acid (all-trans), as well as
retinoic acid (13-cis)), also bind as potential substrates to P450-T3, suggesting that P450-T3 may be used
for the production of biopharmaceuticals. Embelin and its derivatives are used in cancer treatments
and display other biological activities [72]. Retinoic acid (all-trans) and retinoic acid (13-cis) are two
main substances used in dermatology for acne as well as steroid-damaged skin treatment, despite of
some negative effects [73–75]. It will, therefore, be of high interest to investigate their conversion by
P450-T3 and to identify the formed products.
Since steroids are broadly marketed drugs, together with antibiotics and antibodies,
their derivatives have attracted much attention. Steroid hydroxylation results in hydroxylated products
with high level of biological activity [76]. Interestingly, P450-T3 was able to convert testosterone into
two products. However, under the conditions used here, the ratio of conversion only reached ~ 11% in
total. A variety of factors may affect testosterone conversion, such as an insufficient redox partner,
improper temperature, and/or the inappropriate ratio of the components in the reconstituted system.
The role of P450-T3 in Binh Chau hot spring environment, as well as the sequences of putative natural
reductases and ferredoxins, which can serve as redox partners of P450-T3, is still unexplored. It is
thus of high interest to identify a thermostable redox partner to finally optimize the condition for
substrate conversion and to be able to characterize the obtained products of substrate conversion.
Despite the presently low catalytic efficiency of testosterone conversion, this is, to the best of our
knowledge, the first report of testosterone conversion of a thermostable P450 and of a member of the
CYP109C subfamily.
Taken together, our findings demonstrate that P450-T3 is a novel thermostable P450 with an
astonishing broad ability to bind different kinds of substrate. It might be a potential biocatalyst for
versatile drug production. These results also are very useful for further biochemical studies and
biotechnological applications of P450-T3.
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4. Materials and Methods
4.1. Materials
The 1158 bp ORF encoding for P450-T3, comprising 385 amino acids, was subjected in this study.
This ORF was synthesized and ligated into pUC19 vector by Phusa Biochem Ltd. (Cantho, Vietnam).
The nucleotide and amino acid sequences of P450-T3 were deposited in the NCBI GenBank under the
accession number MT232930.
The E. coli strain Top 10 was purchased from Invitrogen (San Diego, CA, USA). The E. coli strain
C43(DE3) was obtained from Agilent Technologies (Santa Clara, CA, USA).
The ORF of P450-T3 was cloned into a pET17b plasmid (Novagen, Darmstadt,
Germany) using the forward primes 5′-gatccatatgggccttggcagcttcca-3′ and the reverse primes
5′-gatcaagcttagtggtgatggtgatgatgctgggccttgagctgcagca-3′ that contained NdeI and HindIII restriction
sites (underline), respectively. These primers were synthesized by MWG Biotech AG (Ebersberg,
Germany).
Embelin, retinoic acid (all-trans), retinoic acid (13-cis) were kindly provided by Dr. Stephan
Lütz (Novartis, Basel, Switzerland). A couple of redox partner enzymes, such as the mammalian
AdR-Adx4-108, the yeast Arh1-Etp1, and the Bacillus systems (BmCPR-Fdx2, BmCPR-Fdx3),
were supported by the Department of Biochemistry, University of Saarland (Saarbrücken, Germany).
All other chemicals and reagents were of the highest grade available.
4.2. Methods
4.2.1. Bioinformatics Analysis
The DNA sequence was translated using the ExPaSy Translate tool (https://www.expasy.org/).
Identification of close homologs was performed using the Basic Local Alignment Search Tool (BLAST,
NCBI) and Dr. Nelson’s Cytochrome P450 Homepage [77]. Alignment of multiple amino acid sequences
was performed with Clustal Omega [78]. Evolutionary analyses were conducted in MEGA X [79].
The evolutionary history was inferred with the maximum likelihood approach and Le_Gascuel
model [80]. The content of secondary elements of proteins was calculated using PRIPRED tool [81].
4.2.2. Production and Purification of P450-T3
The ORF P450-T3 was amplified using the pair of primers described above and cloned into the
pET17b vector (Novagen, Darmstadt, Germany) with the NdeI/HindIII restriction sites. The clones
(pET-T3) were checked with both restriction enzymes before sequencing by MWG Biotech AG
(Ebersberg, Germany).
The vector pET-T3 was transformed into E. coli C43(DE3), competent cells for heterologous gene
expression. The main culture was inoculated at 37 ◦C in 250 mL Terrific Broth (TB) medium containing
100 µg/mL ampicillin to achieve an OD600 of 0.8–1. Protein production was induced by adding 1 mM
isopropyl-β-D-thiogalactopyranoside (IPTG) and 0.5 mM δ-aminolevulinic acid as a precursor for
heme synthesis. The cells were harvested after 48 h expression at 30 ◦C and shaken at 150 rpm.
The cell pellets were resuspended and sonicated in 50 mL lysis buffer (50 mM potassium phosphate
buffer, pH 7.4, containing 20% glycerol, 0.1 mM dithioerythritol, 500 mM sodium acetate, and 1 mM
phenylmethanesulfonyl flouride) [32]. The lysate was centrifuged at 35,000 rpm and 4 ◦C for 30 min.
Cell debris was removed and the supernatant was loaded onto a Ni-NTA agarose column equilibrated
with lysis buffer. After washing with 100 mL of the equilibration buffer containing a gradient of
20–50 mM imidazole, protein was eluted with 20 mL elution buffer (50 mM potassium phosphate,
pH 7.4, containing 1% Tween 20, 10% glycerol, 0.1 mM dithioerythritol, 0.1 mM phenylmethanesulfonyl
fluoride, and 200 mM imidazole). Fractions with A417:A280 >1.6 were collected and dialyzed overnight
to remove imidazole. The protein was concentrated by Centriprep (Millipore, MA, USA) with a pore
size of 50 kDa and 30 kDa to the expected volume before storing at −80 ◦C.
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The concentration of P450 enzyme was estimated by CO difference spectroscopy assuming
∆ε (450–490) = 91 mM−1 * cm−1 as described by Omura and Sato [26]. UV-visible spectra for the
purified P450 enzyme was recorded at room temperature from 200 to 700 nm on a double-beam
spectrophotometer (UV2101PC, Shimadzu, Kyoto, Japan).
4.2.3. Circular Dichroism Spectroscopy
The far-UV CD spectra (195–260 nm) and the near-UV spectra (300–450 nm) were recorded with 4
and 20 µM purified P450-T3, respectively, in 10 mM potassium phosphate buffer pH 7.4 at 25 ◦C on a
JASCO J715 spectropolarimeter, as described by Khatri et al. [38]. Molar ellipticity [θ] was calculated
in deg*cm2/dmol using the following equation:
[θ] = mo * M/(10 * L * C) (1)
where mo is the CD millidegree, M is the average molecular weight of P450-T3 (g/mol), L is path length
of cell (cm), and C is concentration of sample.
4.2.4. Thermal Stability
The optimal temperature of P450-T3 was identified by CO difference spectroscopy. Enzyme samples
(10 µM) were incubated for 15 min at 40, 50, 60, and 70 ◦C, respectively, and the retained amount of the
active form of P450 (absorption in the CO spectrum at 450 nm) was estimated.
The enzyme melting curve was evaluated from its far-UV CD spectrum as an important measure
of thermal stability. The purified protein was dissolved in 20 mM of mM potassium phosphate
buffer pH 7.4 to obtain a concentration of 20 µM. The enzyme was scanned using a Chirascan CD
spectrometer between 190–260 nm while recording every 1 nm for 0.5 s per nm with a bandwidth of
5 nm. Each spectrum was acquired independently three times. Then, the melting curve was obtained
by monitoring the CD at 211 nm over a temperature range 25–95 ◦C at a rate of 1 ◦C per min. At each
temperature, the enzyme was able to equilibrate for 30 s before recording the CD. Melting temperature
was obtained from the second-derivative plots of the melting curve.
Another parameter related to enzyme stability is the enzyme half-life inactivation (T1/2).
To determine T1/2, the purified P450-T3 was dissolved in 20 mM potassium phosphate buffer, pH 7,
and incubated at 60 ◦C. Samples were taken every 15 min, and the residual absorption at 450 nm in the
CO difference spectrum was measured. The T1/2 index was calculated by the following equation:
T1⁄2 = ln 2/Kd (2)
where Kd is the first-order rate constants determined by linear regression of ln (residual absorption at
450 nm) versus the incubation time (t) [82,83].
4.2.5. Investigation of Electron Transfer Partners
The functional interaction of the electron transfer partners for a P450-T3 was examined by
recording the NADPH reduced CO-complex peak at 450 nm when P450-T3 was combined with the
different ferredoxins(Fdx2/Fdx3/Adx4-108 or Etp1)/ferredoxin reductase (BmCPR, AdR or Arh1) pairs
in the absence of substrate, as described by Milmim et al. [32].
4.2.6. Monitoring of Substrate Binding
The substrate binding of the enzyme was followed by a transition of Soret bands from low-spin
state which shows a maximal peak at 417 nm to high-spin state where the maximal peak raised at
around 390 nm. The measurement was carried out by adding substrates in the excess ratio of 1:15 or 1:20
and monitored in the range of 200–700 nm at room temperature on a double-beam spectrophotometer
(UV2101PC, Shimadzu, Kyoto, Japan). The kind of substrates varied from fatty acids (palmitic acid
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and lauric acid) to metabolites (embelin, retinoic acid (all-trans) and retinoic acid (13-cis)) and steroids
(11-deoxycorticosterone (DOC), 11-deoxycortisol (RSS), progesterone, and testosterone).
4.2.7. In Vitro Conversion of Testosterone and HPLC Analysis
A reconstituted in vitro system was used in a final volume of 250 µL at 37 ◦C in a buffer (50 mM
HEPES, pH 7.4, and 20% glycerol) which consisted of 1 µM P450-T3, 2.5 µM AdR, 20 µM Adx4-108,
1 mM MgCl2, 5 mM glucose-6-phosphate, 1 U glucose-6-phosphate dehydrogenase, and 100 µM
testosterone. The addition of 200 µM NADPH started the conversion. After 30 min, the conversion
was stopped by adding ethyl acetate (250 µL) and extracted twice. The negative control was carried
out parallel in the absence of enzyme to verify the P450-dependent reaction. The organic phase was
evaporated before resolving the precipitate by acetonitrile for HPLC analysis.
HPLC analyses were performed on the Jasco system (Gross-Umstadt, Germany) consisting of a
Pu-980 HPLC pump, an AS-950 sampler, a UV-975 UV/visible detector, and an LG-980-02 gradient unit.
Steroids and their metabolites were observed by a UV-Vis detector at 240 nm and 25 ◦C when crossing
the Macherey–Nagel CC125/4 Nucleodur C18ec column (3 µm, 125 × 4.0 mm, Macherey–Nagel, Düren,
NRW, Germany) with gradient elution from 10% to 100% acetonitrile over 30 min.
5. Conclusions
In this study, a novel thermostable cytochrome P450-T3 from the Binh Chau hot spring
metagenomics database was identified, synthesized, expressed, and characterized. The enzyme
had a higher optimal temperature (60 ◦C) compared to mesophilic cytochrome P450s with a melting
temperature at 76.2 ◦C. P450-T3 exhibited a broad substrate binding ability, including lauric acid,
palmitic acid, embelin, retinoic acid (all trans), retinoic acids (13-cis), and testosterone. We further
identified heterologous redox partners for this P450 and investigated the conversion of testosterone,
which was shown to be converted by P450-T3 into two products. Our results contribute to the database
of natural thermostable cytochrome P450s, which is still limited so far. Furthermore, the enzyme
toolbox can be expanded with thermostable P450s via an uncultured approach, which is useful for
biotechnological applications in the future.
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39. Abdulmughni, A.; Jóźwik, I.K.; Brill, E.; Hannemann, F.; Thunnissen, A.-M.W.H.; Bernhardt, R. Biochemical
and structural characterization of CYP109A2, a vitamin D3 25-hydroxylase from Bacillus megaterium. FEBS J.
2017, 284, 3881–3894. [CrossRef]
40. Khatri, Y.; Girhard, M.; Romankiewicz, A.; Ringle, M.; Hannemann, F.; Urlacher, V.B.; Hutter, M.C.;
Bernhardt, R. Regioselective hydroxylation of norisoprenoids by CYP109D1 from Sorangium cellulosum So
ce56. Appl. Microbiol. Biotechnol. 2010, 88, 485–495. [CrossRef]
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